BN Business News
Añadir empresa →
Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.

Negocios · 26/11/20011 min de lectura

Oral Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Soluble Powder; Technical Amendment

Traducción automática local · Idioma original de la fuente

Resumen

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Bimeda, Inc., that provides for a revised withdrawal time for use of oxytetracycline hydrochloride soluble powder in the drinking water of turkeys and swine. The regulations are also being amended to reflect approval of an additional pail size, which was approved under ANADA 200-144 on June 26, 1995; however, inadvertently this change has not yet been made in title 21 CFR. This document corrects that omission and improves the accuracy of the regulations.

Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →